HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jelle Dylus Selected Research

Antineoplastic Agents (Antineoplastics)

12/2016Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/mTOR, Aurora Kinase and EZH2 Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jelle Dylus Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 12/2016
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021
1Ovarian Epithelial Carcinoma
12/2020
1Ovarian Neoplasms (Ovarian Cancer)
12/2020
1Ascites
12/2020
1Colorectal Neoplasms (Colorectal Cancer)
06/2017
1Aneuploidy (Aneuploid)
06/2017

Drug/Important Bio-Agent (IBA)

3Phosphotransferases (Kinase)IBA
01/2022 - 06/2017
1AZD 6244IBA
12/2021
1ruxolitinibIBA
12/2021
1SteroidsIBA
12/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2021
1Epithelial Cell Adhesion MoleculeIBA
12/2020
1Paclitaxel (Taxol)FDA LinkGeneric
12/2020
1PlatinumIBA
12/2020
1ibrutinibIBA
01/2019
12- (4- morpholinoanilino)- 6- cyclohexylaminopurineIBA
06/2017
1NTRC 0066-0IBA
06/2017
1Antineoplastic Agents (Antineoplastics)IBA
12/2016
1Investigational DrugsIBA
12/2016

Therapy/Procedure

3Therapeutics
01/2022 - 06/2017
1Drug Therapy (Chemotherapy)
12/2020